Although IL-4 is long associated with CD4 Th2 immune responses, its role in Th2 subset development in non-lymphoid tissues is less clear. We sought to better define IL-4's role in CD4 Th2 responses by using transgenic mice that express a dual IL-4 AmCyan/ IL-13 DsRed (IL-4AC/IL-13DR) fluorescent reporter on an IL-4-sufficient or IL-4-deficient background. Using primary Th2 immune response models against house dust mite or Nippostrongylus brasiliensis (Nb) allergens, we examined the requirement for IL-4 by each of the defined Th2 subsets in the antigen draining lymph node, skin, and lung tissues. In the lymph node, a CXCR5 In the non-lymphoid dermal or lung tissues of allergen primed or Nb-infected mice, three strikingly distinct T cell subsets could be detected that were IL-4AC, or IL-4AC/IL-13DR, or IL-13DR CD4. The IL-4-and IL-4/IL-13-expressing subsets were significantly reduced in IL-4-deficient mice, while the numbers of IL-13-expressing CD4 T cells were not affected by IL-4 deficiency indicating that other factors can play a role in directing the development of this Th2 subtype. Taken together, these data indicate that the appearance of IL-4-expressing Tfh cells in the lymph node is not dependent on IL-4 while the appearance of IL-4-expressing Th2 subsets in the lymph node and IL-4, IL-4/IL-13-expressing Th2 subsets in skin and lung tissues of antigen primed mice is significantly IL-4 dependent.
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The cytokine IL-4 is understood to be key to the development of type 2 immune responses that underlie allergic disease pathologies and immunity to parasites; however, the specific role IL-4 plays in CD4 T cell differentiation is less clear. Early investigations using in vitro culture systems revealed the dominant role that IL-4 plays in driving and shaping CD4 Th2 subset differentiation toward expression of the canonical type 2 cytokines IL-4, IL-5, and IL-13 (1, 2) . Although in vivo studies have indicated a role for IL-4 directing Th2 development in the lymph node (3, 4) , further studies revealed a more subtle role for IL-4 with IL-4-expressing Th2 cells appearing in the draining lymph nodes of immunized mice seemingly independent of IL-4 or STAT6 signaling (5, 6) . Other studies have shown that the level of TCR activation can play a role in Th2 differentiation (7) , while recent studies even support the view that Th2 development occurs in the tissues and is fully regulated by tissue-specific checkpoints (8) . In addition, TSLP elicited basophils have been shown to promote epicutaneous sensitization to food antigens and subsequent IgE mediated food allergy through IL-4 (9) . We took the opportunity to clarify the role of IL-4 in in vivo CD4 Th2 subset differentiation by asking whether certain specific Th2 subsets are more sensitive to the influence of IL-4 and whether IL-4-is required for Th2 subset development at non-lymphoid tissue sites such as the skin and lung. For the in vivo immune response studies, we used our recently developed antigen priming ear model (10) to quantitatively analyze the character, kinetics and magnitude of the IL-4-and IL-13-producing Th2 subsets that appear in the ear and ear draining lymph node following allergen priming (11, 12) . To examine the appearance Th2 subsets in the lung, we used Nippostrongylus brasiliensis infection model which involves a lung migration stage in its infection cycle (13) . In following the appearance of IL-4-and IL-13-expressing Th2 subsets, we were concerned to reduce artifact and bias inherent in restimulation and intracellular cytokine staining techniques and previously reported reporter IL-4 knockout mice (14) (15) (16) . Therefore, we used the validated sensitivity of the recently developed Il4 and Il13 transcriptional reporter 4C13R mice (17) to investigate the appearance of IL-4-AmCyan (IL-4AC)-and IL-13-DsRed (IL-13DR)-expressing CD4 + T cells arising in both the lymphoid and non-lymphoid tissues responding to house dust mite (HDM) or Nippostrongylus brasiliensis (Nb) allergens in either an IL-4-sufficient or -deficient environment. The Il4AC/ Il13DR reporter BAC transgene construct is independent of the endogenous Il4/Il13 locus in the mouse and appears able to faithfully report the commitment of CD4 T cells to the expression of the canonical type 2 cytokine gene expression pattern (17) (18) (19) under the appropriate tissue culture and relevant in vivo immunization protocols without affecting normal type 2 immune effector functions (20) . We were able to detect both IL-4-expressing Tfh and Th2 cells in the draining lymph nodes of HDM challenged mice and while the small number of IL-4AC Th2 cells was significantly reduced by removal of IL-4, the Tfh cells were independent of the need for IL-4. Strikingly, analysis of the CD4 T cells that migrated to the skin 7 days after the allergen challenge revealed three functionally distinct Th2 subsets that could be defined by their cytokine expression patterns, IL-4AC, IL-4AC/IL-13DR, and IL-13DR only. The appearance of the IL-4AC-and IL-4AC/ IL-13DR-expressing Th2 cell subsets was highly dependent on IL-4 while the IL-13DR Th2 subset was not affected by the IL-4-deficient background. Taken together, our findings reveal the fundamental role that IL-4 plays in the development of functionally diverse effector Th2 subsets in tissues and lymph node. We also identify a novel IL-13-producing CD4 + Th2 subset that appears in the skin following allergen challenge and does not require IL-4 for expression of IL-13. 
MaTerials anD MeThODs
Mice
ear immunizations
Mice were anesthetized using xylazine and ketamine (Phoenix, New Zealand). 30 µl of a solution containing 200 µg HDM (Greer Laboratories, Lenoir, NC, USA) or 600 dead L3 Nb was injected into the ear pinnae as described (10) .
Nb infection
Mice were inoculated with 550 L3 Nb larvae by s.c. injection.
cell isolation
All tissues were isolated 7 days posttreatment. Auricular draining lymph nodes were pressed through 70-μm cell strainers into complete media [IMDM (GIBCO) supplemented with 5% FBS (Sigma), 100 U/ml penicillin/100 μg/ml streptomycin (Invitrogen), and 55 µM β-mercaptoethanol (Invitrogen)] to make a singlecell suspension. Dorsal and ventral ear sheets were separated and minced into very fine pieces using scissors. Each ear was digested by incubating for 30 min at 37°C with shaking, in ear digestion mix [IMDM (GIBCO) containing 1.2 mg/ml Collagenase IV (Sigma) and 120 μg/ml DNAse I (Roche)]. Solution was pipetted up and down and passed through 70-μm cell strainers into Ear wash buffer [PBS containing 1% BSA (Sigma), 5 mM EDTA (Invitrogen), and 120 μg/ml DNAse I (Roche)]. Cells were washed once more in Ear wash buffer before resuspension in cIMDM. Bronchoalveolar lavage (BAL) was performed by cannulation of mice and washing airways three times with PBS. Lungs were finely minced and digested in lung digestion mix [IMDM (GIBCO) containing 2.4 mg/ml Collagenase I (GIBCO) and 120 μg/ml DNAse I (Roche)] for 1 h at 37°C. Live cell counts performed using a hemocytometer and trypan blue (Invitrogen) exclusion.
In Vitro restimulation
Day 7 ear lymph node cells (1 × 10 6 /well) were cultured for 19 h on plates coated with 1 μg/ml anti-CD3 (145-2C11) with cIMDM, 100 U/ml rIL-2, and 1/50 dilution of anti-CD28 (37.51) supernatant corresponding to 5 μg/ml.
Facs analysis
Cells were resuspended in a buffer containing 0.01% NaN3 (Sigma), 2% FBS, and 2 mM EDTA (Life Technologies) in PBS then incubated with anti-CD16/32 antibody (clone 2.4G2) before staining with fluorophore-conjugated antibodies. Cells were stained with antibodies against the following molecules (clone, conjugate; source): CD45 (30-F11, APC-Cy7, BD), CD3 (145-2C11, BV786; BD), CD3 (145-2C11, BUV395; BD), CD4 (RM4-5, BV605; BD), CD4 (GK1.5, APC-Cy7; BD), CD8 (53-6.7, AF700; BioLegend), TCRγδ (GL3, PE-Cy7; BioLegend), CD44 (IM7, APC; BD), CXCR5 (2G8, Biotin; BD), and PD-1 (RMP1-30, PerCP-ef710; eBioscience). Streptavidin-BV605 (BD) was also used. Stained cells were resuspended in viability dye DAPI to exclude dead cells. IL-4 and IL-13 were detected by the IL-4AC and IL-13DR reporters in 4C13R mice. Data were acquired on a BD LSRFortessa SORP flow cytometer (Becton Dickinson, San Jose, CA, USA). Flow data were analyzed using FlowJo software (Treestar).
statistical analysis and graphics
Statistical analyses were performed using GraphPad Prism software (GraphPad Software Inc., San Diego, CA, USA). Statistical comparisons used are specified in figure legends. To determine if the IL-4AC-expressing Th2 cells in the ear lymph node have the potential to produce IL-13DR upon in vitro restimulation, ear lymph node cells were harvested 7 days post HDM priming, and the whole lymph node cell population was cultured on anti-CD3 for 19 h. Stimulated CD4 cells expressed a similar proportion of IL-4AC as they did ex vivo (2.7%), while the percentage of CD4 T cells expressing IL-4AC cultured without anti-CD3 reduced over the time of culture (1.5%). Restimulation of the CD4 T cell subsets did not induce any further IL-13DR expression above background levels, indicating that the failure to detect IL-13DR expression in the lymph node was not due to lack of activation but rather the level of differentiation of the IL-4AC
These data demonstrate that following allergen priming in the ear tissue, distinct Th2 subsets develop in the draining lymph node and tissues. Specifically, CD4 T cells become committed to IL-4AC expression in both lymph node and tissues while the commitment of CD4 T cells to IL-13DR expression only occurs in the tissue.
Both Tfh cells and Th2 cells contribute to il-4 expression in the lymph node after hDM challenge Figure 2D ). In addition, the IL-4AC
+ Tfh cells showed a higher level of CD44 expression than the IL-4AC + Th2 cells ( Figure 2E ). The biological impact of this statistically significant difference is unclear.
Thus, it would appear from these data that following HDM introduction to the skin, CD4 T cells in the draining lymph node become committed to activated Tfh and Th2 phenotypes some of which express IL-4 and contribute to IL-4 production in the ear draining lymph node. Interestingly, Tfh cells also expressed higher levels of the IL-4AC reporter, perhaps suggesting a higher capacity to secrete IL-4.
il-4 Plays a role in the Development of il-4ac-expressing lymph node Th2 cells but not il-4ac-expressing Tfh cells Thus, it appears that the number of IL-4AC + Tfh cells in the lymph node is independent of IL-4, while Th2 CD4 cells in the ear lymph node are partially dependent on IL-4 for their development.
il-4 is required for the Development of il-4ac-and il-4ac/il-13Dr-expressing Th2 subsets, but not il-13Dr-expressing cD4 + T cell subset, in ear Tissue
We next studied the role of IL-4 in the development of Th2 subsets in the ear tissue following priming with either HDM or Nb allergens. As observed in Figure 1 , three subsets of IL-4AC-or IL-13DR-expressing Th2 cells were identified in the ear after priming with HDM ( Figures 4A,B) or dead Nb (Figures 4F,G) . In both primary immunization models, the number of IL-13DR single-positive Th2 cells was not affected by the absence of IL-4 ( Figures 4C,H) , nor was there a reduction in the amount of IL-13DR they expressed as determined by MFI (Figures 4E,J) . Although the proportion of IL-13DR Th2 cells was higher in IL-4 −/− mice primed with non-viable Nb compared with IL-4-sufficient controls (Figure 4G) , analysis of the total cell numbers revealed no difference (Figure 4H) , due to the reduced overall numbers of CD4
+ T cells present in the IL-4 −/− mouse (data not shown), suggesting that the higher proportion was simply due to the lack of other cell subsets in the IL-4 −/− ear tissue. By contrast, the number of IL-4AC single-positive CD4 cells that appeared in the allergen primed ear tissue was reduced 8-fold in HDM immunized and an even greater 16-fold in Nb immunized 4C13R-IL-4 −/− mice (Figures 4C,H) . The IL-4AC/IL-13DR double reporter-expressing Th2 subset was also dependent on IL-4, with a threefold reduction in their levels observed in 4C13R-IL-4 −/− mice in both models. Even though similar proportions of these cells were found in dead Nb immunized IL-4 +/+ and IL-4 −/− mice (Figure 4G) , their numbers were reduced in the IL-4-deficient (Figures 4D,I ). Thus, as well as a significant reduction in the numbers of IL-4AC-expressing Th2 cells being detected in IL-4-deficient 4C13R-IL-4 −/− mice, the gene expression from the Il4 locus, as determined by examining reporter expression, was also reduced. As previously noted with IL-4-sufficient mice (Figure 1G) , dual reporter IL-4AC + / IL-13DR + Th2 cells from 4C13R-IL-4 −/− mice also expressed greater levels of IL-4AC and IL-13DR reporters than the single reporter positive cells (Figures 4D,E,I,J) .
To determine whether the distinct IL-4AC-and IL-13DR-expressing Th2 subsets could also develop at other tissue sites following antigen priming, we examined the Th2 subsets generated in the lung and BAL of mice responding to a live primary Nb infection, in which larvae infect the lung before migrating to the gut. We observed in both lung tissue and airways (BAL) the same three CD4 ) mice were primed with HDM and their ear draining lymph nodes and ear tissue examined after 7 days. As reported in Figure 3 , IL-4AC + Tfh cells in the lymph node were not dependent on IL-4, whereas levels of IL-4AC + Th2 cells were halved when IL-4 was not available (Figure 5A) . Contrary to the IL-4-deficient system, the number of IL-4AC + Th2 cells in the hemizygous lymph nodes were the same as those in IL-4 wild-type mice indicating that even with reduced IL-4 availability the IL-4AC + Th2 cell response to HDM in the draining lymph node is capable of full development. In the tissue, however, the hemizygous Il4 condition had a far more striking effect on the development of the IL-4AC + Th2 subset, with a fivefold reduction in cell numbers to levels only twofold greater than in the absence of IL-4 ( Figure 5B) . The reduction of the IL-4AC
+ Th2 subset in the ear was less pronounced and, as was seen in Figure 4 , the IL-13DR + Th2 cells were independent of IL-4 for their appearance in ear tissue. The disproportionate effect that the loss of half the wild-type IL-4 has on the IL-4AC 
DiscUssiOn
We sought to clarify the role of IL-4 in the differentiation, migration, and accumulation of CD4 + T cells following a primary response to allergen. We followed the number of IL-4-and IL-13-expressing CD4 T cells that appear in the draining lymph node and subsequent type 2 inflammatory response in the skin or lung following intradermal priming with allergen or parasite infection, respectively. We confirm that during the 7-day priming period the appearance of IL-4-expressing Tfh cells in the lymph node is not dependent on IL-4, while the appearance of IL-4-expressing Th2 cells in the lymph node is partially affected by the absence of IL-4. We describe for the first time the profound requirement for IL-4 in regulating the appearance of IL-4-and IL-4/IL-13-expressing Th2 subsets in the skin tissue 7 days following allergen priming. A similar IL-4 response profile was found for IL-4-producing Th2 cells in the lungs of Nb challenged mice. Surprisingly, we identified a unique CD4 T cell subset in the skin that was induced by both allergen priming in the skin and parasite infection in the lung that was committed solely to IL-13 expression and was completely independent of IL-4. Although normally IL-13 expression in CD4 T cells is linked to IL-4 expression and it is viewed as one of the canonical Th2 cytokines which is regulated by IL-4, a previous study using IL-4/IL-13 reporter mice identified that IL-13 expression occurs in lung tissue but not lymph nodes and that IL-4 and IL-13 expression is not always linked (23) . Here, using our HDM skin priming model, we complement this data with confirmation in the ear skin tissue and its draining lymph node of the confinement of IL-13-expressing Th2 cells to the tissue compartment, while IL-4-expressing Th2 subsets reside in both lymphoid and non-lymphoid tissues. Furthermore, our finding that in vitro restimulation did not elicit IL-13 expression in CD4 T cells derived from the draining lymph node of HDM ear immunized mice confirms that the failure to detect IL-13 is not a sensitivity issue of the reporter system but rather whether the CD4 T cells have received the appropriate signals for activation of the Il13 gene. The identification in the tissues of primed mice of a unique subset of CD4 T cells that only expressed IL-13 and whose appearance was independent of IL-4 was surprising. When viewed in the context of recent work by others (8, 24) and our recent data showing that TSLP can regulate the development of an IL-13-producing CD4 Th2 subset (25) , it becomes clear that other factors such as tissue alarmins are likely able to regulate or act as a tissue checkpoint for a IL-13-producing Th2 subset in the tissues.
T follicular helper cells have been shown to be a significant source of IL-4 in the lymph nodes during the Th2 response (21) . In our studies following HDM priming of the ear skin, we find that both Tfh and Th2 cells contribute to IL-4 expression in the ear lymph node, although the Tfh cells had a greater degree of activation and made a greater amount of IL-4 than their Th2 counterparts, perhaps to aid their role helping B cells to class switch to IgE and IgG1 production. Tfh cells are traditionally thought to reside in the B cell follicle of the lymph nodes, but recent research has suggested that additionally Tfh cells may be precursors of Th2 cells subsequently found in the tissues (26, 27) . Using a multiple prime and challenge lung model, Ballesteros et al. showed that HDM sensitization induced IL-4-committed Tfh cells in the lymph node which developed into IL-4-and IL-13-producing effector Th2 cells in the lung upon HDM challenge (26) . Other research has identified a subset of Th2 promoting IL-21-expressing Tfh cells, distinct from Th2 cells, found in both the lymph node and lung tissue (27) . Whether or not the Tfh cells seen in the ear lymph node in our ear HDM priming model are distinct from the ear tissue Th2 subsets remains to be determined. In addition, the link between the IL-4 + Th2 subset seen in the lymph node and those Th2 subsets in the ear is unclear and subject to further research. It is probable that IL-4-expressing Th2 cells migrate from the lymph node to the ear tissue where they produce additional Th2 cytokines such as IL-5 and IL-13 for Th2 effector functions, perhaps under response to local damage elicited tissue signals (8) . Of the IL-4-producing CD4
+ subsets in the lymph node, the Th2 subset is more likely than the Tfh cells to be the precursors of the tissue Th2 subsets, as both the Th2 subsets, but not Tfh cells demonstrate a dependence on IL-4 for their development. It should be noted though that the MFIs of the IL-4AC reporter were significantly reduced in both the Tfh and Th2 lymph node CD4 T cells subsets indicating that the levels of IL-4 may be regulated through indirect means such as signaling by B cells or dendritic cells.
That the development of IL-4-expressing Tfh cells is independent of IL-4 adds to current recognition of Tfh cells being a unique subset distinct from traditional Th2 cells. Development of Tfh cells instead depends on IL-6, IL-21, STAT3, and BCL6 and not on other cytokine or transcription factors necessary for formation of other T helper subsets (28) (29) (30) , and it has been reported that the Tfh cell transcription factor BCL6 can limit the activities of Th2 cells (31) . However, it should be noted that studies by others show that the IL-4-producing Th2 subset in the lymph node is not affected by BCL6 deletion indicating that the Tfh subset may not be a precursor for lymph node Th2 (32) . Our studies identify a second IL-4-expressing CD4 T cell subset in the lymph node that does not express Tfh markers but whose expression of IL-4 appears to be partially IL-4 dependent. In support of our finding, recent studies have shown that IL-4Rα knockout mice exhibited a significantly compromised IL-4-expressing Th2 response in the gut draining mesenteric lymph node of H. polygyrus-infected mice (33) As IL-4Rα is a component of the receptors via which both IL-4 and IL-13 act, this could be attributed to the inability of IL-4 (or IL-13) to act via its receptor. In our studies, generation of IL-4AC-expressing lymph node Th2 cells was not effected in mice lacking one IL-4 allele and was only reduced by half in the complete absence of IL-4, thus showing only a partial requirement for IL-4. This suggests that although IL-4 contributes to Th2 differentiation in the lymph node other factors are likely involved, such as the quality of the TCR signal and co-stimulation, Th2 promoting miRNAs, signaling pathways that promote GATA3 expression, and other Th2 promoting cytokines like TSLP, IL-33, and IL-25 (34) (35) (36) (37) (38) (39) . In contrast to our present findings, previous research using G4 reporter mice has indicated that IL-4 was not required to generate IL-4-expressing Th2 cells in the lymph nodes of Nb-infected mice (6). However, in these studies only G4/IL4 heterozygous mice in which IL-4 was produced from only one allele could be compared with IL-4-deficient G4/G4 mice in the various allergen and parasitic models and no difference in numbers of GFP-expressing 
Il13
+/Tom mice were used, which due to the insertion of the reporter constructs, are hemizygous for the IL-4 and IL-13 cytokines. They found that IL-4eGFP-expressing CD4 + T cells were largely absent from the lung while in the mediastinal lymph node they were present and major contributors to IL-4 production. This replicates what we have seen in IL-4 hemizygous mice in our current study (Figure 5) , where IL-4AC + Th2 cells are not sensitive to the partial loss of IL-4 in the lymph node but in the ear tissue are sensitive to even the hemizygous IL-4 state, with severely decreased numbers. The reliance on IL-4-knockin reporter mice fails to achieve an accurate representation of cytokine expression in a fully IL-4-sufficient environment, while the 4C13R reporter mice overcome this limitation. However, it should be noted that studies using gene expression reporter constructs do not necessarily give any indication of the protein levels that are produced by these Th2 cells and further studies would be required to determine whether the gene expression findings reported here translate into protein expression.
In addition to the IL-4-expressing Tfh subset, we have identified using IL-4AC and IL-13DR expression three subsets of CD4 + T cells that would fall under the definition of a Th2 effector cell that is primed by allergen (or parasite antigens) in the draining lymph node and then migrate and expresses functional cytokines at the original antigen challenged tissue site. The IL-4-and IL-4/ IL-13-expressing Th2 subsets are very dependent on IL-4 for their appearance in the tissues. Although outside the scope of this study, the requirement for IL-4 may be either to (i) allow differentiation/survival of differentiating Th2 subsets to Il4 and Il13 gene expression, (ii) regulate migration and extravasation of CD4 Th2 subsets to antigen challenged tissue sites or (iii) its continued presence is required when reactivated with antigen at the tissue site for full differentiation to a IL-4-or IL-4/IL-13-expressing Th2 effector to occur. Also, our observation that a distinct IL-13-expres sing CD4 T cell subset appears in tissues following antigen challenge that is not regulated by IL-4 may reflect the ability of specific tissue-derived alarmins to program specific cytokine expression patterns. Taken together, a picture emerges whereby the differentiating Th2 cell appears to be regulated by multiple checkpoints at distinct tissue sites (Figure 6 ). The lymph node appears to be a place for antigen priming and activation of naïve T cells to Th2 precursors, some of which sequester to the B cell areas of the lymph node to drive B cell differentiation and the others to quickly circulate throughout the body and home to the tissue sites challenged with priming antigens. IL-4 and specific tissue-derived alarmins and factors appear able at this point to direct the further differentiation of the Th2 precursors to distinct subsets of IL-4-, IL-4/IL-13-, and IL-13-expressing subsets. The value or relevance of each Th2 effector subset to the process of antigen/pathogen neutralization, clearance, and repair needs to be elucidated by further studies.
The development of reagents which can selectively interfere with the actions of Th2 cytokines is a potential therapeutic approach in the treatment of allergic disorders, and antibodies targeting the individual cytokines and their receptors have met with variable results [reviewed in Ref (41) ]. Dupilumab that blocks IL4Rα, a subunit of both the IL-4 and IL-13 receptors, interferes with the action of both these cytokines and to date has had success in treating asthma and atopic dermatitis (42, 43) . The ability of this drug to simultaneously target and block the functions of the lymph node and tissue Th2 cells, thus inhibiting humoral and cellular aspects of type 2-driven pathology is likely key to its success. Further insights into the nature of IL-4-and IL-13-producing Th2 subsets generated in response to allergic stimuli will beneficially further the understanding of the anti-allergic effects of these agents and contribute to their ongoing development.
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